The COVID-19 public health emergency (PHE) may be ending May 11, but the Drug Enforcement Administration (DEA) is proposing rules that would allow health care practitioners to continue to prescribe some controlled substances via telehealth.
Sean Sullivan, Anthony Fanucci, and Sofia Molodanof discuss the two long-awaited proposed rules creating new telehealth exceptions to the Ryan Haight Act:
- Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation
- Expansion of Induction of Buprenorphine via Telemedicine Encounter
They also discuss how the proposed rules impact providers and how to weigh in on the rulemaking.
Subscribe to Our Health Care Updates >
View More Healthy Bytes > | Return to Digital Transformation of Health Care >